Cancer Biology & Medicine最新文献

筛选
英文 中文
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer. 高精度免疫相关血浆蛋白质组学分析预测三阴性乳腺癌患者对免疫治疗的反应
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-07-04 DOI: 10.20892/j.issn.2095-3941.2025.0038
Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang, Jinxiu Shi
{"title":"High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer.","authors":"Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang, Jinxiu Shi","doi":"10.20892/j.issn.2095-3941.2025.0038","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0038","url":null,"abstract":"<p><strong>Objective: </strong>While immunotherapy holds great potential for triple-negative breast cancer (TNBC), the lack of non-invasive biomarkers to identify beneficiaries limits the application.</p><p><strong>Methods: </strong>Paired baseline, on-treatment, and post-treatment plasma samples were collected from 195 TNBC patients receiving anti-PD-1 immunotherapy in this retrospective study conducted at the Fudan University Shanghai Cancer Center (FUSCC) for sequential high-precision proteomic profiling.</p><p><strong>Results: </strong>ARG1, NOS3, and CD28 were identified as plasma proteins significantly associated with the response to immunotherapy in neoadjuvant settings or in advanced stages of TNBC. Matched single-cell RNA sequencing data were incorporated to correlate peripheral plasma with the tumor microenvironment. Furthermore, the Plasma Immuno Prediction Score was developed to demonstrate significant predictive power for evaluating the efficacy and prognosis of patients undergoing neoadjuvant immunotherapy.</p><p><strong>Conclusions: </strong>The results underscore the importance of systemic immunity in the immunotherapy response and support the use of plasma protein profiles as a feasible tool for enhancing personalized management of immunotherapy in breast cancer.</p>","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144559305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast surgeons at the forefront: preserving lymph nodes for enhanced immunotherapy efficacy. 最前沿的乳房外科医生:保留淋巴结以提高免疫治疗效果。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-07-03 DOI: 10.20892/j.issn.2095-3941.2025.0251
Zhiqiang Shi, Qiuchen Zhao, Yongsheng Wang, Pengfei Qiu
{"title":"Breast surgeons at the forefront: preserving lymph nodes for enhanced immunotherapy efficacy.","authors":"Zhiqiang Shi, Qiuchen Zhao, Yongsheng Wang, Pengfei Qiu","doi":"10.20892/j.issn.2095-3941.2025.0251","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0251","url":null,"abstract":"","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144559304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neutrophils in cancer: from immune defense to tumor promotion. 中性粒细胞在癌症中的作用:从免疫防御到肿瘤促进。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-07-02 DOI: 10.20892/j.issn.2095-3941.2025.0023
Zhen Wang, Hanwen Hu, Yunjia Bao, Liwei Pang, Chenghui Yang
{"title":"Neutrophils in cancer: from immune defense to tumor promotion.","authors":"Zhen Wang, Hanwen Hu, Yunjia Bao, Liwei Pang, Chenghui Yang","doi":"10.20892/j.issn.2095-3941.2025.0023","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0023","url":null,"abstract":"<p><p>Neutrophils are the protagonists of the host immune response, possessing potent antimicrobial and inflammatory capacities. The neutrophil reservoir as well as the development, mobilization, chemotaxis, pro-inflammatory activity, and clearance of neutrophils are strictly regulated to prevent inflammation-induced tissue damage. Inflammation pervades almost every type of cancer. However, there is growing awareness that although the tumor microenvironment has the capacity to recruit neutrophils, the functions are diverse and include roles other than that of sentinels in cancer. This review highlights the heterogeneity of neutrophils in tumors, discusses the dual role of neutrophils as angels and demons in tumorigenesis, invasion, and metastasis, and examines the potential of neutrophils as targets in clinical therapy.</p>","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PI3Kβ moonlights as a protein kinase: driving fatty acid metabolism and histone acetylation in cancer. PI3Kβ作为蛋白激酶:在癌症中驱动脂肪酸代谢和组蛋白乙酰化。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-06-27 DOI: 10.20892/j.issn.2095-3941.2025.0216
Yixin Duan, Juanjuan Liu, Jianxin Xu, Jing Fang
{"title":"PI3Kβ moonlights as a protein kinase: driving fatty acid metabolism and histone acetylation in cancer.","authors":"Yixin Duan, Juanjuan Liu, Jianxin Xu, Jing Fang","doi":"10.20892/j.issn.2095-3941.2025.0216","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0216","url":null,"abstract":"","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma. 超越黄金:金糠蛋白在黑色素瘤中的化学增强机制和治疗潜力。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-06-27 DOI: 10.20892/j.issn.2095-3941.2025.0026
Xiaofeng Wang, Yingnan Liu, Wuqiong Zhang, Zhongda Li, Su Li, Jiaxin Chen, Qi Li, Xiaoman Suo, Yanqiao Zeng, Guofang Zhang, Yang Li
{"title":"Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma.","authors":"Xiaofeng Wang, Yingnan Liu, Wuqiong Zhang, Zhongda Li, Su Li, Jiaxin Chen, Qi Li, Xiaoman Suo, Yanqiao Zeng, Guofang Zhang, Yang Li","doi":"10.20892/j.issn.2095-3941.2025.0026","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0026","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the current study was to evaluate the chemosensitizing capacity of auranofin (AF), a gold (I) complex traditionally used in rheumatoid arthritis treatment, in potentiating the cytotoxic effects of doxorubicin (DOX) in melanoma cell models, specifically drug-sensitive (B16F10) and multidrug-resistant (B16F10/ADR) variants.</p><p><strong>Methods: </strong>Experimental measurements, including <i>in vitro</i> cytotoxicity and apoptosis assays, surface plasmon resonance (SPR), immunoblotting assays, as well as theoretical calculations, such as molecular docking and molecular dynamics (MD) simulations, were used to systematically delineate the interaction dynamics between AF and thioredoxin reductase 1 (TrxR1). The anti-tumor efficacy of co-treatment with AF and DOX was assessed by examining cell viability and apoptotic rates.</p><p><strong>Results: </strong>Co-treatment with AF and DOX significantly increased anti-tumor efficacy, as evidenced by reduced cell viability and increased apoptotic rates. This synergistic effect was attributed to inhibition of TrxR1 by AF, which compromised tumor cell antioxidant defenses and elevated intracellular reactive oxygen species (ROS), thereby enhancing apoptotic pathways. Notably, AF treatment mitigated the heightened TrxR activity in DOX-resistant cells, intensifying the pro-oxidant effects of DOX, leading to increased ROS production and cell death. The data also showed that AF binds with high affinity to the selenocysteine residue within the catalytic site of TrxR1, which partially overlapped with the binding site of the endogenous substrate, thioredoxin (Trx), but with greater avidity. This unique binding configuration impedes the reduction of Trx by TrxR1, triggering an apoptotic response in cancer cells.</p><p><strong>Conclusions: </strong>This study underscores the chemosensitizing potential of AF in overcoming multidrug resistance in cancer therapy through redox modulation. The molecular mechanism of action underlying AF on TrxR1 demonstrated the unique binding configuration that impedes the reduction of Trx by TrxR1 and instigates an apoptotic response in cancer cells. These findings pave the way for the clinical application of AF as a chemosensitizer, offering a novel approach to augment the efficacy of existing chemotherapy regimens.</p>","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications. XPO1作为小细胞肺癌的关键调节因子:机制、生物标志物和治疗意义
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-06-27 DOI: 10.20892/j.issn.2095-3941.2025.0215
Tingting Qin, Jingya Wang, Dingzhi Huang
{"title":"XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications.","authors":"Tingting Qin, Jingya Wang, Dingzhi Huang","doi":"10.20892/j.issn.2095-3941.2025.0215","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0215","url":null,"abstract":"","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased and persistent absolute CD4+ T cell count in an HIV-associated Burkitt lymphoma patient with central nervous system involvement after axicabtagene ciloleucel therapy. 阿克他格尼吉莱治疗后,伴有中枢神经系统受累的hiv相关伯基特淋巴瘤患者CD4+ T细胞绝对计数增加并持续存在。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-06-27 DOI: 10.20892/j.issn.2095-3941.2025.0087
Yao Qi, Jia Wang, Jingyi Li, Qi Deng
{"title":"Increased and persistent absolute CD4+ T cell count in an HIV-associated Burkitt lymphoma patient with central nervous system involvement after axicabtagene ciloleucel therapy.","authors":"Yao Qi, Jia Wang, Jingyi Li, Qi Deng","doi":"10.20892/j.issn.2095-3941.2025.0087","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0087","url":null,"abstract":"","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-omics in colorectal cancer liver metastasis: applications and research advances. 多组学在结直肠癌肝转移中的应用及研究进展。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-06-26 DOI: 10.20892/j.issn.2095-3941.2025.0066
Kexue Zhou, Chengxiang Yang, Yan Li
{"title":"Multi-omics in colorectal cancer liver metastasis: applications and research advances.","authors":"Kexue Zhou, Chengxiang Yang, Yan Li","doi":"10.20892/j.issn.2095-3941.2025.0066","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0066","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is a common malignant tumor with a high mortality rate worldwide. Advanced CRC often leads to liver metastasis, which has a poor prognosis, highlighting the need to investigate the underlying mechanisms. Omics, encompassing genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics, enables comprehensive molecular analysis of cells and tissues. Tumor-omics research has advanced rapidly, with growing attention on CRC-related omics. However, systematic reviews on omics research specific to colorectal cancer liver metastasis (CRLM) are limited. This review summarizes the current status and progress of multi-omics research on CRLM and discusses the application of multi-omics technologies in basic research and the significant clinical implications.</p>","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dissection of the TNM staging classification for nasopharyngeal cancer - past, present, and future. 鼻咽癌TNM分期分类的分析——过去、现在和将来。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-06-26 DOI: 10.20892/j.issn.2095-3941.2025.0170
Qin Liu, Anne W M Lee
{"title":"Dissection of the TNM staging classification for nasopharyngeal cancer - past, present, and future.","authors":"Qin Liu, Anne W M Lee","doi":"10.20892/j.issn.2095-3941.2025.0170","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2025.0170","url":null,"abstract":"","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National prevention programs and their effects on gastric cancer Incidence and mortality in East Asian countries. 东亚国家胃癌预防计划及其对胃癌发病率和死亡率的影响。
IF 5.6 2区 医学
Cancer Biology & Medicine Pub Date : 2025-06-20 DOI: 10.20892/j.issn.2095-3941.2024.0561
Min Cai, Ruiqi Xia, Ziyang Wang, Ruoxin Zhang, Wanghong Xu
{"title":"National prevention programs and their effects on gastric cancer Incidence and mortality in East Asian countries.","authors":"Min Cai, Ruiqi Xia, Ziyang Wang, Ruoxin Zhang, Wanghong Xu","doi":"10.20892/j.issn.2095-3941.2024.0561","DOIUrl":"https://doi.org/10.20892/j.issn.2095-3941.2024.0561","url":null,"abstract":"","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":"22 5","pages":""},"PeriodicalIF":5.6,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144474004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信